BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
FABP1
,
glucose metabolic process
,
Pseudomonas infection
,
Kidney
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IGFBP-%203
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for IGFBP-%203
Explore Curated Studies Results
Literature
Most Relevant Literature
PM2.5 exposure exaggerates the risk of adverse birth outcomes in pregnant women with pre-existing hy…
Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytom…
Specific amino acid substitutions determine the differential contribution of the N- and C-terminal d…
Insulin-like growth factors and their binding proteins in pleural fluid.
The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PROMComplete for Determination of Rupture of Fetal Membranes
China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in …
Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study
A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week C…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ